NIH-funded research R21 grant

How alcohol affects ulcerative colitis symptoms

Official title: IL-22-STAT3-Nos2 axis in alcohol-mediated exacerbation of UC pathology

Funded at Loyola University Chicago · NIH-10869469 · Data updated 2026-11-12

This study looks at how drinking alcohol affects people with ulcerative colitis by making their symptoms worse and increasing the chance of infections, using mice to understand the changes in gut bacteria and inflammation that happen because of alcohol.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLoyola University Chicago
NIH-funded
Lab location1 site (Maywood, United States)
Project startAugust 22, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$213,000
NIH project number1R21AA031560-01
Project IDNIH-10869469 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with ulcerative colitis who consume alcohol.

Less likely to help

Patients without a diagnosis of ulcerative colitis or those who do not consume alcohol may not benefit from this research.

What this research studies

This research investigates the impact of alcohol consumption on patients with ulcerative colitis (UC), focusing on how it exacerbates symptoms and increases the risk of intestinal infections. The study uses a mouse model to explore the mechanisms behind these effects, particularly looking at changes in gut bacteria and inflammatory responses. By examining the IL-22-STAT3-Nos2 signaling pathway, the research aims to understand how alcohol alters the gut environment and contributes to disease progression. Patients may gain insights into the risks associated with alcohol use in relation to their UC condition.

Why it matters

Potential benefit: If successful, this research could lead to better management strategies for ulcerative colitis patients who consume alcohol.

How similar studies have gone: Previous research has indicated that alcohol can worsen gastrointestinal diseases, suggesting that this study builds on established findings rather than exploring a completely novel approach.

Where this research is happening

  • Loyola University Chicago
    Maywood, United States
    Active

Researchers

  • Principal investigator: Choudhry, Mashkoor a — Loyola University Chicago
  • Study coordinator: Choudhry, Mashkoor a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.